Results 21 to 30 of about 103,759 (240)
Guillain-Barré syndrome: expanding the concept of molecular mimicry.
Trends in immunology, 2022 Guillain-Barré syndrome (GBS) is a rapidly progressive, monophasic, and potentially devastating immune-mediated neuropathy in humans. Preceding infections trigger the production of cross-reactive antibodies against gangliosides concentrated in human ...
J. Laman +3 more
semanticscholar +1 more source
Guillain-Barre syndrome in 220 patients with COVID-19
The Egyptian Journal of Neurology Psychiatry and Neurosurgery, 2021 This review summarises and discusses recent findings concerning the pathophysiology, clinical presentation, diagnosis, treatment, and outcome of SARS-CoV-2-associated Guillain-Barre syndrome (SC2-GBS).
J. Finsterer, F. Scorza
semanticscholar +1 more source
Journal of Neurology, 2020 Since coronavirus disease-2019 (COVID-19) outbreak in January 2020, several pieces of evidence suggested an association between the spectrum of Guillain–Barré syndrome (GBS) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Samir Abu-Rumeileh +4 more
semanticscholar +1 more source
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
medRxiv, 2020 Background Reports of Guillain-Barre Syndrome (GBS) have emerged during the Coronavirus Disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS.
S. Keddie +41 more
semanticscholar +1 more source
Guillain-Barré syndrome after COVID-19 vaccination
BMJ Case Reports, 2021 We report a case of Guillain-Barré syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca).
Norma McKean, Charmaine Chircop
semanticscholar +1 more source
Diagnosis and management of Guillain–Barré syndrome in ten steps
Nature Reviews Neurology, 2019 Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases,
S. Leonhard +20 more
semanticscholar +1 more source
BMJ Case Reports, 2021 Prevention strategies for COVID-19 transmission are at the forefront of healthcare paradigms worldwide, the main emphasis of which is vaccination. We present an interesting case of a 37-year-old man who, 3 weeks following his first dose of the chimpanzee
Shreena Patel +3 more
semanticscholar +1 more source
Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects
Nature Reviews Neurology, 2021 The epidemiology, clinical characteristics, management and outcome of Guillain–Barré syndrome (GBS) differ between low-income and middle-income countries (LMIC) and high-income countries (HIC).
Nowshin Papri +5 more
semanticscholar +1 more source
Neurology Research International, 2019 Introduction. Guillain-Barre syndrome is the most common cause of acute flaccid paralysis in the adult population. It occurs at the rate of 0.34 to 4 per 100000 individuals.
Saroj Kumar Bhagat +4 more
doaj +1 more source
Reversible stress cardiomyopathy in Guillain-Barré syndrome: a case report
Journal of Medical Case Reports, 2019 Background Guillain-Barré syndrome is an autoimmune disorder in which autoantibodies mainly affect the peripheral nervous system. Autonomic dysfunction is a common and severe complication of Guillain-Barré syndrome.
A. Gravos +9 more
doaj +1 more source